Skip to main navigation Skip to search Skip to main content

1-Year Patency of Biorestorative Polymeric Coronary Artery Bypass Grafts in an Ovine Model

  • Masafumi Ono
  • , Shigetaka Kageyama
  • , Neil O'Leary
  • , Mohammed S. el-Kurdi
  • , Jochen Reinöhl
  • , Eric Solien
  • , Richard W. Bianco
  • , Mirko Doss
  • , Bart Meuris
  • , Renu Virmani
  • , Martijn Cox
  • , Yoshinobu Onuma
  • , Patrick W. Serruys*
  • *Corresponding author for this work
  • Amsterdam UMC
  • University of Galway
  • Xeltis B.V.
  • LLC
  • University of Minnesota Twin Cities
  • Helios Clinic
  • KU Leuven
  • CVpath Institute Inc., a Non-profit Organization in Gaithersburg, Gaithersburg, MD, USA
  • Imperial College London

Research output: Contribution to journalArticleAcademicpeer-review

16 Downloads (Pure)

Abstract

Many attempts have been made to inhibit or counteract saphenous vein graft (SVG) failure modes; however, only external support for SVGs has gained momentum in clinical utility. This study revealed the feasibility of implantation, and showed good patency out to 12 months of the novel biorestorative graft, in a challenging ovine coronary artery bypass graft model. This finding could trigger the first-in-man trial of using the novel material instead of SVG. We believe that, eventually, this novel biorestorative bypass graft can be one of the options for coronary artery bypass graft patients who have difficulty harvesting SVG.
Original languageEnglish
Pages (from-to)19-34
Number of pages16
JournalJACC. Basic to translational science
Volume8
Issue number1
DOIs
Publication statusPublished - 1 Jan 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • coronary artery bypass graft
  • coronary artery disease
  • coronary revascularization
  • polymeric bypass graft
  • preclinical model
  • quantitative flow ratio
  • restorative vascular graft

Fingerprint

Dive into the research topics of '1-Year Patency of Biorestorative Polymeric Coronary Artery Bypass Grafts in an Ovine Model'. Together they form a unique fingerprint.

Cite this